Selected research
Market Analysis & Forecast
Global Prescription Automation Market Analysis and Forecast 2026-2032
Market perspective
The global Prescription Automation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Prescription Automation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Prescription Automation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Prescription Automation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Prescription Automation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Prescription Automation include McKesson, iA, BD, Omnicell, Yuyama, Baxter, TOSHO, Takazono and ScriptPro, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Prescription Automation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Prescription Automation, also provides the revenue of main regions and countries. Of the upcoming market potential for Prescription Automation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prescription Automation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prescription Automation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prescription Automation revenue, projected growth trends, production technology, application and end-user industry.
Prescription Automation Segment by Company
McKesson
iA
BD
Omnicell
Yuyama
Baxter
TOSHO
Takazono
ScriptPro
SmartCabinet
ARxIUM
Willach
QuiqMeds
KNAPP
WellSky
Capsa Healthcare (RoboPharma)
MedAvail Technologies
NewIcon
Asteres
Prescription Automation Segment by Type
Automated Medication Dispensing
Automated Packaging and Central Fill
Automated Storage and Retrieval
Automated Medication Compounding
Others
Prescription Automation Segment by Application
Central Filling Pharmacy
Mail Order/Digital Pharmacy
Hospital Pharmacy
Retail Pharmacy
Pharmaceutical Wholesale
Prescription Automation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Automation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Automation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Automation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Prescription Automation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Prescription Automation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Automation revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Medication Dispensing
- Automated Packaging and Central Fill
- Automated Storage and Retrieval
- Automated Medication Compounding
- Others
Applications
- Central Filling Pharmacy
- Mail Order/Digital Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
- Pharmaceutical Wholesale
Companies covered
- McKesson
- iA
- BD
- Omnicell
- Yuyama
- Baxter
- TOSHO
- Takazono
- ScriptPro
- SmartCabinet
- ARxIUM
- Willach
- QuiqMeds
- KNAPP
- WellSky
- Capsa Healthcare (RoboPharma)
- MedAvail Technologies
- NewIcon
- Asteres
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Prescription Automation Market by Type
- 1.2.1 Global Prescription Automation Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Automated Medication Dispensing
- 1.2.3 Automated Packaging and Central Fill
- 1.2.4 Automated Storage and Retrieval
- 1.2.5 Automated Medication Compounding
- 1.2.6 Others
- 1.3 Prescription Automation Market by Application
- 1.3.1 Global Prescription Automation Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Central Filling Pharmacy
- 1.3.3 Mail Order/Digital Pharmacy
- 1.3.4 Hospital Pharmacy
- 1.3.5 Retail Pharmacy
- 1.3.6 Pharmaceutical Wholesale
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Prescription Automation Market Dynamics
- 2.1 Prescription Automation Industry Trends
- 2.2 Prescription Automation Industry Drivers
- 2.3 Prescription Automation Industry Opportunities and Challenges
- 2.4 Prescription Automation Industry Restraints
3 Global Growth Perspective
- 3.1 Global Prescription Automation Market Perspective (2021-2032)
- 3.2 Global Prescription Automation Growth Trends by Region
- 3.2.1 Global Prescription Automation Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Prescription Automation Market Size by Region (2021-2026)
- 3.2.3 Global Prescription Automation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Prescription Automation Revenue by Players
- 4.1.1 Global Prescription Automation Revenue by Players (2021-2026)
- 4.1.2 Global Prescription Automation Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Prescription Automation Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Prescription Automation Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Prescription Automation Key Players Headquarters & Area Served
- 4.4 Global Prescription Automation Players, Product Type & Application
- 4.5 Global Prescription Automation Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Prescription Automation Market CR5 and HHI
- 4.6.3 2025 Prescription Automation Tier 1, Tier 2, and Tier 3
5 Prescription Automation Market Size by Type
- 5.1 Global Prescription Automation Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Prescription Automation Revenue by Type (2021-2032)
- 5.3 Global Prescription Automation Revenue Market Share by Type (2021-2032)
6 Prescription Automation Market Size by Application
- 6.1 Global Prescription Automation Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Prescription Automation Revenue by Application (2021-2032)
- 6.3 Global Prescription Automation Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 McKesson
- 7.1.1 McKesson Company Information
- 7.1.2 McKesson Business Overview
- 7.1.3 McKesson Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.1.4 McKesson Prescription Automation Product Portfolio
- 7.1.5 McKesson Recent Developments
- 7.2 iA
- 7.2.1 iA Company Information
- 7.2.2 iA Business Overview
- 7.2.3 iA Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.2.4 iA Prescription Automation Product Portfolio
- 7.2.5 iA Recent Developments
- 7.3 BD
- 7.3.1 BD Company Information
- 7.3.2 BD Business Overview
- 7.3.3 BD Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.3.4 BD Prescription Automation Product Portfolio
- 7.3.5 BD Recent Developments
- 7.4 Omnicell
- 7.4.1 Omnicell Company Information
- 7.4.2 Omnicell Business Overview
- 7.4.3 Omnicell Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.4.4 Omnicell Prescription Automation Product Portfolio
- 7.4.5 Omnicell Recent Developments
- 7.5 Yuyama
- 7.5.1 Yuyama Company Information
- 7.5.2 Yuyama Business Overview
- 7.5.3 Yuyama Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.5.4 Yuyama Prescription Automation Product Portfolio
- 7.5.5 Yuyama Recent Developments
- 7.6 Baxter
- 7.6.1 Baxter Company Information
- 7.6.2 Baxter Business Overview
- 7.6.3 Baxter Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.6.4 Baxter Prescription Automation Product Portfolio
- 7.6.5 Baxter Recent Developments
- 7.7 TOSHO
- 7.7.1 TOSHO Company Information
- 7.7.2 TOSHO Business Overview
- 7.7.3 TOSHO Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.7.4 TOSHO Prescription Automation Product Portfolio
- 7.7.5 TOSHO Recent Developments
- 7.8 Takazono
- 7.8.1 Takazono Company Information
- 7.8.2 Takazono Business Overview
- 7.8.3 Takazono Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.8.4 Takazono Prescription Automation Product Portfolio
- 7.8.5 Takazono Recent Developments
- 7.9 ScriptPro
- 7.9.1 ScriptPro Company Information
- 7.9.2 ScriptPro Business Overview
- 7.9.3 ScriptPro Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.9.4 ScriptPro Prescription Automation Product Portfolio
- 7.9.5 ScriptPro Recent Developments
- 7.10 SmartCabinet
- 7.10.1 SmartCabinet Company Information
- 7.10.2 SmartCabinet Business Overview
- 7.10.3 SmartCabinet Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.10.4 SmartCabinet Prescription Automation Product Portfolio
- 7.10.5 SmartCabinet Recent Developments
- 7.11 ARxIUM
- 7.11.1 ARxIUM Company Information
- 7.11.2 ARxIUM Business Overview
- 7.11.3 ARxIUM Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.11.4 ARxIUM Prescription Automation Product Portfolio
- 7.11.5 ARxIUM Recent Developments
- 7.12 Willach
- 7.12.1 Willach Company Information
- 7.12.2 Willach Business Overview
- 7.12.3 Willach Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.12.4 Willach Prescription Automation Product Portfolio
- 7.12.5 Willach Recent Developments
- 7.13 QuiqMeds
- 7.13.1 QuiqMeds Company Information
- 7.13.2 QuiqMeds Business Overview
- 7.13.3 QuiqMeds Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.13.4 QuiqMeds Prescription Automation Product Portfolio
- 7.13.5 QuiqMeds Recent Developments
- 7.14 KNAPP
- 7.14.1 KNAPP Company Information
- 7.14.2 KNAPP Business Overview
- 7.14.3 KNAPP Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.14.4 KNAPP Prescription Automation Product Portfolio
- 7.14.5 KNAPP Recent Developments
- 7.15 WellSky
- 7.15.1 WellSky Company Information
- 7.15.2 WellSky Business Overview
- 7.15.3 WellSky Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.15.4 WellSky Prescription Automation Product Portfolio
- 7.15.5 WellSky Recent Developments
- 7.16 Capsa Healthcare (RoboPharma)
- 7.16.1 Capsa Healthcare (RoboPharma) Company Information
- 7.16.2 Capsa Healthcare (RoboPharma) Business Overview
- 7.16.3 Capsa Healthcare (RoboPharma) Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.16.4 Capsa Healthcare (RoboPharma) Prescription Automation Product Portfolio
- 7.16.5 Capsa Healthcare (RoboPharma) Recent Developments
- 7.17 MedAvail Technologies
- 7.17.1 MedAvail Technologies Company Information
- 7.17.2 MedAvail Technologies Business Overview
- 7.17.3 MedAvail Technologies Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.17.4 MedAvail Technologies Prescription Automation Product Portfolio
- 7.17.5 MedAvail Technologies Recent Developments
- 7.18 NewIcon
- 7.18.1 NewIcon Company Information
- 7.18.2 NewIcon Business Overview
- 7.18.3 NewIcon Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.18.4 NewIcon Prescription Automation Product Portfolio
- 7.18.5 NewIcon Recent Developments
- 7.19 Asteres
- 7.19.1 Asteres Company Information
- 7.19.2 Asteres Business Overview
- 7.19.3 Asteres Prescription Automation Revenue and Gross Margin (2021-2026)
- 7.19.4 Asteres Prescription Automation Product Portfolio
- 7.19.5 Asteres Recent Developments
8 North America
- 8.1 North America Prescription Automation Revenue (2021-2032)
- 8.2 North America Prescription Automation Revenue by Type (2021-2032)
- 8.2.1 North America Prescription Automation Revenue by Type (2021-2026)
- 8.2.2 North America Prescription Automation Revenue by Type (2027-2032)
- 8.3 North America Prescription Automation Revenue Share by Type (2021-2032)
- 8.4 North America Prescription Automation Revenue by Application (2021-2032)
- 8.4.1 North America Prescription Automation Revenue by Application (2021-2026)
- 8.4.2 North America Prescription Automation Revenue by Application (2027-2032)
- 8.5 North America Prescription Automation Revenue Share by Application (2021-2032)
- 8.6 North America Prescription Automation Revenue by Country
- 8.6.1 North America Prescription Automation Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Prescription Automation Revenue by Country (2021-2026)
- 8.6.3 North America Prescription Automation Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Prescription Automation Revenue (2021-2032)
- 9.2 Europe Prescription Automation Revenue by Type (2021-2032)
- 9.2.1 Europe Prescription Automation Revenue by Type (2021-2026)
- 9.2.2 Europe Prescription Automation Revenue by Type (2027-2032)
- 9.3 Europe Prescription Automation Revenue Share by Type (2021-2032)
- 9.4 Europe Prescription Automation Revenue by Application (2021-2032)
- 9.4.1 Europe Prescription Automation Revenue by Application (2021-2026)
- 9.4.2 Europe Prescription Automation Revenue by Application (2027-2032)
- 9.5 Europe Prescription Automation Revenue Share by Application (2021-2032)
- 9.6 Europe Prescription Automation Revenue by Country
- 9.6.1 Europe Prescription Automation Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Prescription Automation Revenue by Country (2021-2026)
- 9.6.3 Europe Prescription Automation Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Prescription Automation Revenue (2021-2032)
- 10.2 China Prescription Automation Revenue by Type (2021-2032)
- 10.2.1 China Prescription Automation Revenue by Type (2021-2026)
- 10.2.2 China Prescription Automation Revenue by Type (2027-2032)
- 10.3 China Prescription Automation Revenue Share by Type (2021-2032)
- 10.4 China Prescription Automation Revenue by Application (2021-2032)
- 10.4.1 China Prescription Automation Revenue by Application (2021-2026)
- 10.4.2 China Prescription Automation Revenue by Application (2027-2032)
- 10.5 China Prescription Automation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Prescription Automation Revenue (2021-2032)
- 11.2 Asia Prescription Automation Revenue by Type (2021-2032)
- 11.2.1 Asia Prescription Automation Revenue by Type (2021-2026)
- 11.2.2 Asia Prescription Automation Revenue by Type (2027-2032)
- 11.3 Asia Prescription Automation Revenue Share by Type (2021-2032)
- 11.4 Asia Prescription Automation Revenue by Application (2021-2032)
- 11.4.1 Asia Prescription Automation Revenue by Application (2021-2026)
- 11.4.2 Asia Prescription Automation Revenue by Application (2027-2032)
- 11.5 Asia Prescription Automation Revenue Share by Application (2021-2032)
- 11.6 Asia Prescription Automation Revenue by Country
- 11.6.1 Asia Prescription Automation Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Prescription Automation Revenue by Country (2021-2026)
- 11.6.3 Asia Prescription Automation Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Prescription Automation Revenue (2021-2032)
- 12.2 SAMEA Prescription Automation Revenue by Type (2021-2032)
- 12.2.1 SAMEA Prescription Automation Revenue by Type (2021-2026)
- 12.2.2 SAMEA Prescription Automation Revenue by Type (2027-2032)
- 12.3 SAMEA Prescription Automation Revenue Share by Type (2021-2032)
- 12.4 SAMEA Prescription Automation Revenue by Application (2021-2032)
- 12.4.1 SAMEA Prescription Automation Revenue by Application (2021-2026)
- 12.4.2 SAMEA Prescription Automation Revenue by Application (2027-2032)
- 12.5 SAMEA Prescription Automation Revenue Share by Application (2021-2032)
- 12.6 SAMEA Prescription Automation Revenue by Country
- 12.6.1 SAMEA Prescription Automation Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Prescription Automation Revenue by Country (2021-2026)
- 12.6.3 SAMEA Prescription Automation Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst